Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$1.66 - $2.79 $7,244 - $12,175
4,364 Added 40.41%
15,163 $26,000
Q2 2022

Aug 09, 2022

SELL
$1.44 - $3.98 $286,670 - $792,326
-199,077 Reduced 94.85%
10,799 $19,000
Q1 2022

May 12, 2022

BUY
$2.97 - $5.2 $623,331 - $1.09 Million
209,876 New
209,876 $754,000
Q4 2021

Feb 10, 2022

SELL
$4.99 - $7.46 $394,684 - $590,048
-79,095 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.16 - $9.69 $566,320 - $766,430
79,095 New
79,095 $566,000
Q2 2021

Aug 13, 2021

SELL
$6.23 - $10.03 $311,288 - $501,158
-49,966 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $440,200 - $847,423
49,966 New
49,966 $463,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $499M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.